Paper39769271
Impact of T Cell Exhaustion and Stroma Senescence on Tumor Cell Biology and Clinical Outcome of Head and Neck Squamous Cell Carcinomas.
Brust LA and 9 others. Int J Mol Sci, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Impact of T Cell Exhaustion and Stroma Senescence on Tumor Cell Biology and Clinical Outcome of Head and Neck Squamous Cell Carcinomas. Papers, record 39769271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39769271
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of T Cell Exhaustion and Stroma Senescence on Tumor Cell Biology and Clinical Outcome of Head and Neck Squamous Cell Carcinomas.
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tumor Microenvironment | Major topic |
| Squamous Cell Carcinoma of Head and Neck | Major topic |
| Head and Neck Neoplasms | Major topic |
| Programmed Cell Death 1 Receptor | Major topic |
| Biomarkers, Tumor | Major topic |
| Hepatitis A Virus Cellular Receptor 2 | Major topic |
| Humans | |
| Male | |
| Female | |
| Middle Aged | |
| Aged | |
| Lymphocyte Activation Gene 3 Protein | |
| Lymphocytes, Tumor-Infiltrating | |
| T-Lymphocytes | |
| Adult | |
| Prognosis | |
| Antigens, CD | |
| Cellular Senescence | |
| Stromal Cells | |
| Vitamin D | |
| Matrix Metalloproteinase 3 | |
| Papillomavirus Infections | |
| T-Cell Exhaustion |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34986285 | Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma. | N Engl J Med | 2022 | https://conductscience.org/library/papers/34986285 | PubMed |
| 2 | 33989559 | Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial. | Lancet Oncol | 2021 | https://conductscience.org/library/papers/33989559 | PubMed |
| 3 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 4 | 28812214 | The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma. | Cancer Metastasis Rev | 2017 | https://conductscience.org/library/papers/28812214 | PubMed |
| 5 | 34354714 | CD8+ T Cell Exhaustion in Cancer. | Front Immunol | 2021 | https://conductscience.org/library/papers/34354714 | PubMed |
| 6 | 33396515 | LAG-3, TIM-3 and VISTA Expression on Tumor-Infiltrating Lymphocytes in Oropharyngeal Squamous Cell Carcinoma-Potential Biomarkers for Targeted Therapy Concepts. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33396515 | PubMed |
| 7 | 35662989 | Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials. | World J Clin Oncol | 2022 | https://conductscience.org/library/papers/35662989 | PubMed |
| 8 | 27271600 | Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27271600 | PubMed |
| 9 | 36917948 | The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. | Cancer Cell | 2023 | https://conductscience.org/library/papers/36917948 | PubMed |
| 10 | 35111155 | Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer. | Front Immunol | 2021 | https://conductscience.org/library/papers/35111155 | PubMed |
| 11 | 29756240 | Vitamin D intake and survival and recurrence in head and neck cancer patients. | Laryngoscope | 2018 | https://conductscience.org/library/papers/29756240 | PubMed |
| 12 | 34368221 | TIM-3 and CEACAM1 are Prognostic Factors in Head and Neck Squamous Cell Carcinoma. | Front Mol Biosci | 2021 | https://conductscience.org/library/papers/34368221 | PubMed |
| 13 | 30228945 | Vitamin D deficiency in head and neck cancer patients - prevalence, prognostic value and impact on immune function. | Oncoimmunology | 2018 | https://conductscience.org/library/papers/30228945 | PubMed |
| 14 | 27718784 | Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27718784 | PubMed |
| 15 | 21739672 | T cell exhaustion. | Nat Immunol | 2011 | https://conductscience.org/library/papers/21739672 | PubMed |
| 16 | 33897693 | Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis. | Front Immunol | 2021 | https://conductscience.org/library/papers/33897693 | PubMed |
| 17 | 20514052 | Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer. | Cell Mol Immunol | 2010 | https://conductscience.org/library/papers/20514052 | PubMed |
| 18 | 34692707 | Senescence and Immunoregulation in the Tumor Microenvironment. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34692707 | PubMed |
| 19 | 36941602 | Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma. | J Transl Med | 2023 | https://conductscience.org/library/papers/36941602 | PubMed |
| 20 | 36980527 | The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer-Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36980527 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40218858 | Vitamin D and Clinical Outcomes in Head and Neck Cancer: A Systematic Review. | Nutrients | 2025 | https://conductscience.org/library/papers/40218858 |
Source PubMed
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CXCL8 | 3576 | PubTator's text mining | https://conductscience.org/library/genes/3576 | NCBI Gene |
| HAVCR2 | 84868 | PubTator's text mining | https://conductscience.org/library/genes/84868 | NCBI Gene |
| LAG3 | 3902 | PubTator's text mining | https://conductscience.org/library/genes/3902 | NCBI Gene |
| MMP3 | 4314 | PubTator's text mining | https://conductscience.org/library/genes/4314 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39769271
GET https://conductscience.org/api/papers/v1/39769271/references?page=2